|
||||||||||||||||||||||
|
|
||||||||||||||||||||||
|
General Assembly Invitation
|
||||||||||||||||||||||
|
||||||||||||||||||||||
|
Agenda Items
|
||||||||||||||||||||||
|
1 - Opening and Election of the Chairman of Meeting
|
||||||||||||||||||||||
|
2 - Reading, discussion and approval of the Annual Report of year 2024 prepared by the Board of Directors
|
||||||||||||||||||||||
|
3 - Reading of the summary report of the Independent Audit Firm of 2024 Fiscal Period
|
||||||||||||||||||||||
|
4 - Reading, discussion and approval of the Financial Statements of 2024 Fiscal Period
|
||||||||||||||||||||||
|
5 - Acquittal of each member of the Board of Directors in relation to the activities of Company in 2024,
|
||||||||||||||||||||||
|
6 - Approval of the changes to be made in the Company's "Dividend Distribution Policy" for 2025 and the following years, in accordance with the Capital Markets Board regulations.
|
||||||||||||||||||||||
|
7 - Approval, or approval with amendments or refusal of the Board of Directors' proposal for profit distribution for the year 2024 and the distribution date which prepared in accordance with the Company's Profit Distribution Policy,
|
||||||||||||||||||||||
|
8 - Provided that the necessary approvals have been obtained from the Capital Markets Board of Turkey and the Ministry of Trade; approval, or approval with amendment or refusal of the Board of Directors' offer for amending Article 7 titled "Capital" and Article 5 titled "Head Office and Branches of the Company" of the Company Articles of Association,
|
||||||||||||||||||||||
|
9 - Determination of the number and the term of duty of the members of the Board of Directors and election of the members base on the determined number, election of the Independent Board Members
|
||||||||||||||||||||||
|
10 - As per the Corporate Governance Principles, informing and approval the shareholders regarding the "Remuneration Policy for members of the Board of Directors and the Senior Executives" and regarding the payments made under this policy and related payments
|
||||||||||||||||||||||
|
11 - Determination of the annual gross fees to be paid to the members of the Board of Directors
|
||||||||||||||||||||||
|
12 - Approval of the Independent Audit Firm selected by the Board of Directors as per the regulations of the Turkish Commercial Code and Capital Markets Board and Public Oversight Accounting and Auditing Standards
|
||||||||||||||||||||||
|
13 - Giving information to the shareholders regarding the donations made by the Company in 2024 in accordance with the Company's Donation and Sponsorship Policy and determination of an upper limit for donations to be made in 2025
|
||||||||||||||||||||||
|
14 - In accordance with the Capital Markets Board regulations, informing the shareholders about guarantees, pledges, mortgages and surety granted in favor of third parties by the Company and its subsidiaries in 2024 and of any benefits or income
|
||||||||||||||||||||||
|
15 - Authorization of the shareholders that have management control, the members of the Board of Directors, the senior executives and their spouses and relatives related by blood or affinity up to the second degree as per the provisions of articles 395 and 396 of the Turkish Commercial Code and presentation to the shareholders of the transactions carried out thereof in the year 2024 pursuant to the Corporate Governance Communique of the Capital Markets Board,
|
||||||||||||||||||||||
|
16 - Wishes and opinions
|
||||||||||||||||||||||
|
Corporate Actions Involved In Agenda
|
||||||||||||||||||||||
|
||||||||||||||||||||||
|
||||||||||||||||||||||
|
General Assembly Results
|
||||||||||||||||||||||
|
||||||||||||||||||||||
|
Decisions Regarding Corporate Actions
|
||||||||||||||||||||||
|
||||||||||||||||||||||
|
General Assembly Registry
|
||||||||||||||||||||||
|
||||||||||||||||||||||
|
||||||||||||||||||||||
|
Additional Explanations
|
||||||||||||||||||||||
|
2024 Annual General Meeting of our company dated 24.03.2025 was registered by the Istanbul Registry of Commerce on 13.05.2025.
This statement has been translated into English for informational purposes. In case of a discrepancy between the Turkish and the English versions of this disclosure statement, the Turkish version shall prevail.
|